OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Issue Information	394
Issue Information	216
Issue Information	207
	182
	124
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)	115
Issue Information	106
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study	101
Erratum	98
Issue Information	90
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort	83
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers	73
Ramucirumab‐containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum‐based chemotherapy: A multicenter observational retrospective study (W	70
Assessment of long‐term survival in childhood cancer patients using cancer registry data from eastern China: Period analysis outperforms traditional analysis	66
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients	65
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target	64
Dipeptidyl peptidase‐4 in the tumor microenvironment of the digestive system: Molecular mechanisms and therapeutic targets	62
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older	62
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials	62
Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment	60
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study	57
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer	57
Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk	57
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer	56
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center	56

Issue Information	55
Education level and risk of breast cancer by tumor subtype in the EPIC cohort	55
	55
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d	53
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”	53
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study	53
Improving colon cancer screening in Poland. In search of the Holy Grail	52
Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States	52
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study	51
Antiviral prophylaxis for hepatitis B virus reactivation in T‐cell lymphoma patients with resolved hepatitis B virus infection	50
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study	50
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study	50
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study	50
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)	48
Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark	48
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities	46
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review	45
Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8⁺ T‐cell functions via modulating glucose metabolism of CD11b⁺	45
The landscape of genetic aberrations in myxofibrosarcoma	44
Challenges in the future of cancer screening	44